These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 15380354

  • 21. Differential pathogenesis of primary CCR5-using human immunodeficiency virus type 1 isolates in ex vivo human lymphoid tissue.
    Karlsson I, Grivel JC, Chen SS, Karlsson A, Albert J, Fenyö EM, Margolis LB.
    J Virol; 2005 Sep; 79(17):11151-60. PubMed ID: 16103166
    [Abstract] [Full Text] [Related]

  • 22. HIV chemokine receptor inhibitors as novel anti-HIV drugs.
    Princen K, Schols D.
    Cytokine Growth Factor Rev; 2005 Dec; 16(6):659-77. PubMed ID: 16005254
    [Abstract] [Full Text] [Related]

  • 23. CCR5 or CXCR4 use influences the relationship between CD4 cell depletion, NKp44L expression and NK cytotoxicity in SHIV-infected macaques.
    Vieillard V, Habib RE, Brochard P, Delache B, Bovendo HF, Calvo J, Morin J, Picq I, Martinon F, Vaslin B, Le Grand R, Debré P.
    AIDS; 2008 Jan 11; 22(2):185-92. PubMed ID: 18097220
    [Abstract] [Full Text] [Related]

  • 24. Virus replication and disease progression inversely correlate with SIV tat evolution in morphine-dependent and SIV/SHIV-infected Indian rhesus macaques.
    Noel RJ, Kumar A.
    Virology; 2006 Mar 01; 346(1):127-38. PubMed ID: 16313937
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Entry inhibitor-based microbicides are active in vitro against HIV-1 isolates from multiple genetic subtypes.
    Ketas TJ, Schader SM, Zurita J, Teo E, Polonis V, Lu M, Klasse PJ, Moore JP.
    Virology; 2007 Aug 01; 364(2):431-40. PubMed ID: 17428517
    [Abstract] [Full Text] [Related]

  • 28. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
    Irlbeck DM, Amrine-Madsen H, Kitrinos KM, Labranche CC, Demarest JF.
    AIDS; 2008 Jul 31; 22(12):1425-31. PubMed ID: 18614865
    [Abstract] [Full Text] [Related]

  • 29. Viral interactions in human lymphoid tissue: Human herpesvirus 7 suppresses the replication of CCR5-tropic human immunodeficiency virus type 1 via CD4 modulation.
    Lisco A, Grivel JC, Biancotto A, Vanpouille C, Origgi F, Malnati MS, Schols D, Lusso P, Margolis LB.
    J Virol; 2007 Jan 31; 81(2):708-17. PubMed ID: 17065205
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs.
    Harouse JM, Gettie A, Tan RC, Blanchard J, Cheng-Mayer C.
    Science; 1999 Apr 30; 284(5415):816-9. PubMed ID: 10221916
    [Abstract] [Full Text] [Related]

  • 32. Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5.
    Lederman MM, Veazey RS, Offord R, Mosier DE, Dufour J, Mefford M, Piatak M, Lifson JD, Salkowitz JR, Rodriguez B, Blauvelt A, Hartley O.
    Science; 2004 Oct 15; 306(5695):485-7. PubMed ID: 15486300
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The epidemiology of HIV coreceptor tropism.
    Hoffmann C.
    Eur J Med Res; 2007 Oct 15; 12(9):385-90. PubMed ID: 17933718
    [Abstract] [Full Text] [Related]

  • 35. HIV-1 pathogenesis differs in rectosigmoid and tonsillar tissues infected ex vivo with CCR5- and CXCR4-tropic HIV-1.
    Grivel JC, Elliott J, Lisco A, Biancotto A, Condack C, Shattock RJ, McGowan I, Margolis L, Anton P.
    AIDS; 2007 Jun 19; 21(10):1263-72. PubMed ID: 17545702
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Initiation of antiretroviral therapy during chronic SIV infection leads to rapid reduction in viral loads and the level of T-cell immune response.
    Boyer JD, Kumar S, Robinson T, Parkinson R, Wu L, Lewis M, Weiner DB.
    J Med Primatol; 2006 Aug 19; 35(4-5):202-9. PubMed ID: 16872283
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.